Pomalidomide 4'-PEG2-acid (Synonyms: Pomalidomide 4'-PEG2-acid) |
| Catalog No.GC50690 |
Pomalidomida 4'-PEG2-Ácido (Pomalidomida 4'-PEG2-Ácido) es un conjugado ligando-enlazador E3 ligasa sintetizado que incorpora el ligando cereblon basado en pomalidomida y el enlazador PEG de 2 unidades utilizado en la tecnologÍa PROTAC.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2140807-17-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG2 linker with terminal acid ready for conjugation to a target protein ligand. Part of a range of functionalized tool molecules for PROTAC R&D. PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.
Average Rating: 5 (Based on Reviews and 10 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *